Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence F Eichenfield

Showing results (321-330 of 377) with videos related to

Pageof 38
Sort By:
JAMA Dermatology|October 1, 2020
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical TrialKristian Reich, Kenji Kabashima, Ketty Peris, et al.
Pediatrics|May 3, 2013
Evidence-based recommendations for the diagnosis and treatment of pediatric acneLawrence F Eichenfield, Andrew C Krakowski, Caroline Piggott, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 9, 2023
The vIGA-AD scale for atopic dermatitis: Uptake in the past 5 years and position of the International Eczema CouncilRobert Bissonnette, Eric Simpson, Lawrence F Eichenfield, et al.
Advances in Therapy|April 18, 2026
Long-Term Dupilumab Treatment Is Not Associated with an Increased Overall Risk of Infections in Adults with Moderate-to-Severe Atopic Dermatitis: Results from an Open-Label 5-Year Extension StudyLisa A Beck, Eric L Simpson, Diamant Thaçi, et al.
American Journal of Clinical Dermatology|May 9, 2019
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled AnalysisLawrence F Eichenfield, Thomas Bieber, Lisa A Beck, et al.
JAMA Dermatology|March 13, 2024
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult PatientsYael Renert-Yuval, Khaled Ezzedine, Pearl Grimes, et al.
Allergy|January 24, 2024
Impact of climate change on atopic dermatitis: A review by the International Eczema CouncilSheng-Pei Wang, Nicholas Stefanovic, Raquel L Orfali, et al.
Pediatric Dermatology|December 4, 2019
Diaper dermatitis prevalence and severity: Global perspective on the impact of caregiver behaviorAndrew N Carr, Thomas DeWitt, Michael J Cork, et al.
Journal of the American Academy of Dermatology|May 16, 2025
Efficacy and Safety of Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3, a Phase 3, Randomized Double-Blind StudyLawrence F Eichenfield, Linda F Stein Gold, Eric L Simpson, et al.
Journal of the American Academy of Dermatology|December 15, 2022
Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohortKatrina Abuabara, Lawrence F Eichenfield, Robert Bissonnette, et al.
Pageof 38

Showing results (321-330 of 377) with videos related to

Sort By:
Pageof 38
JAMA Dermatology|October 1, 2020
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical TrialKristian Reich, Kenji Kabashima, Ketty Peris, et al.
Pediatrics|May 3, 2013
Evidence-based recommendations for the diagnosis and treatment of pediatric acneLawrence F Eichenfield, Andrew C Krakowski, Caroline Piggott, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 9, 2023
The vIGA-AD scale for atopic dermatitis: Uptake in the past 5 years and position of the International Eczema CouncilRobert Bissonnette, Eric Simpson, Lawrence F Eichenfield, et al.
Advances in Therapy|April 18, 2026
Long-Term Dupilumab Treatment Is Not Associated with an Increased Overall Risk of Infections in Adults with Moderate-to-Severe Atopic Dermatitis: Results from an Open-Label 5-Year Extension StudyLisa A Beck, Eric L Simpson, Diamant Thaçi, et al.
American Journal of Clinical Dermatology|May 9, 2019
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled AnalysisLawrence F Eichenfield, Thomas Bieber, Lisa A Beck, et al.
JAMA Dermatology|March 13, 2024
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult PatientsYael Renert-Yuval, Khaled Ezzedine, Pearl Grimes, et al.
Allergy|January 24, 2024
Impact of climate change on atopic dermatitis: A review by the International Eczema CouncilSheng-Pei Wang, Nicholas Stefanovic, Raquel L Orfali, et al.
Pediatric Dermatology|December 4, 2019
Diaper dermatitis prevalence and severity: Global perspective on the impact of caregiver behaviorAndrew N Carr, Thomas DeWitt, Michael J Cork, et al.
Journal of the American Academy of Dermatology|May 16, 2025
Efficacy and Safety of Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3, a Phase 3, Randomized Double-Blind StudyLawrence F Eichenfield, Linda F Stein Gold, Eric L Simpson, et al.
Journal of the American Academy of Dermatology|December 15, 2022
Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohortKatrina Abuabara, Lawrence F Eichenfield, Robert Bissonnette, et al.
Pageof 38